US Price Control, Outcomes-Based Contracting: Reflections Of Former VA Secretary Shulkin
Executive Summary
The former Secretary of the US Department of Veterans Affairs, David Shulkin, discusses in an interview the US Inflation Reduction Act, telehealth, interoperability of healthcare data, and Mark Cuban’s pharma venture.
You may also be interested in...
Former VA Secretary, Biogen Exec On IRA And Politics, Price Clamps In Europe
A former secretary of the US Department of Veterans Affairs and a senior Biogen executive deliberated at a recent summit the unintended consequences of the US Inflation Reduction Act and politics around the legislation. They likened the first prescription drugs subject to price controls under the IRA to a “TV commercial list.”
Medicare Drug Payment Demonstration May Advance In 2023 Under Executive Order
Demonstration would ‘build on’ Medicare price controls established by the Inflation Reduction Act, White House says.
Medicare Drug Price Control Group Formed At CMS: How Will Stakeholders Interact?
As the Centers for Medicare and Medicaid Services begins the process of building new price negotiation and inflation rebate programs within Medicare, stakeholders are watching to see how transparent the process will be and how much outside input the agency will seek.